Previous studies have identified mutations in five ion channel genes as a cause of long QT syndrome, a heterogeneous disorder characterized by prolongation of the QT interval, multiform ventricular tachycardia (torsades de pointes), seizures, syncope, and sudden death. However, in these studies, the average age of initial symptoms is in the third decade of life or later, and few reports have described the genetic causes of long QT syndrome presenting in the prenatal or neonatal period. We used a candidate gene approach to identify the genetic cause of long QT syndrome in an infant whose initial manifestations were detected in utero. Direct bidirectional sequencing of long QT syndrome genes identified a previously unreported HERG missense mutation (R752Q). Three asymptomatic family members were heterozygous for R752Q, and the proband, who manifested ventricular tachycardia in utero, was homozygous. R752Q was not found in 100 normal unrelated chromosomes. Paternal DNA was unavailable for testing. Transient transfection of HERG generated robust I Kr , but no current was observed for the mutant HERG. The HERG mutant, R752Q, is associated with a mild phenotype, inasmuch as family members with a heterozygous mutation appear unaffected. The homozygous mutation results in absence of functional I Kr , causing a profound loss of HERG channel function, creating the equivalent of a "HERG knockout" and leading to a severe phenotype. LQTS is a heterogeneous disorder characterized by prolongation of the QT interval, multiform ventricular tachycardia (torsades de pointes), seizures, syncope, and sudden death. Heterozygous missense mutations in the HERG gene, which encodes the ␣ subunit of a potassium channel that induces the rapid component of the delayed rectifier current, I Kr , are a common cause of LQTS (1). However, LQTS in the fetus or neonate are not reported in such studies; the initial symptoms in individuals with heterozygous HERG mutations are typically identified in older individuals, on average, in the third decade of life or later (1). We used a candidate gene approach to identify the genetic cause of LQTS in an infant whose initial manifestations were detected in utero. A previously unreported HERG mutation was identified. Family members with a heterozygous mutation had mild or absent phenotype, but the homozygous mutation resulted in a severe phenotype in the proband.
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METHODS
Clinical characteristics. The proband was referred at 38 wk gestational age for evaluation of irregular fetal heart rhythm. Echocardiographic study revealed normal cardiac structure and function. There was no atrioventricular valve regurgitation or signs of hydrops fetalis. Sinus rhythm with 1:1 atrioventricular conduction (120 beats per minute) was the predominant rhythm, but episodes of irregular fetal tachycardia (240 -250 beats per minute) were observed. Simultaneous color Doppler-enhanced M-mode recordings of the fetal atrial and ventricular contractions and great vessel ejection revealed tachycardia with atrioventricular dissociation, consistent with nonsustained ventricular tachycardia.
After uneventful delivery, with birth weight of 2.9 kg, surface ECG showed intermittent second-degree atrioventricular block, sinus rhythm with a prolonged QT c of 0.53 s, and intermittent torsades de pointes (Fig. 1) ; there was no evidence of hearing loss. In the absence of a family history for deafness, syncope, sudden death (infant or adult), drowning, or seizures, ECG from five family members with QT c Ͻ 450 ms were considered normal (Fig. 2) . The father is thought to be living, but physical examination, ECG, and medical history could not be obtained.
Molecular genetic methods. Written informed consent was obtained from all participants in accordance with the Medical University of South Carolina Institutional Review Board for Human Research. A complete family medical history was obtained. An ECG was obtained and 10 mL of whole blood was collected from participating family members. Genomic DNA was extracted as previously described (2) . To identify the molecular genetic basis of long QT syndrome, HERG, KV-LQT1, KCNE1, and KCNE2 were used as candidate genes. The coding regions, including exon/intron boundaries, were amplified from genomic DNA as previously described (1). Bidirectional sequencing was performed using an automated cycle sequencer (ABI Prism 377 Sequencer, ABI BigDye Terminator Cycle Sequencing Kit, Applied Biosystems, Foster City, CA, U.S.A.). Sequence alterations were examined in the context of the open reading frame to determine whether there was corresponding change in the coding sense. Sequence alterations were confirmed by restriction enzyme digest or allele-specific oligonucleotide hybridization (2) .
To exclude the possibility of a chromosome deletion of the HERG gene, three P1 clones containing the HERG gene were isolated from a human genomic library (3) and used to perform fluorescence in situ hybridization (FISH). Digoxigenin-11-dUTP was incorporated into 1 g of DNA from each P1 clone via nick translation (Roche Molecular Biochemicals, Mannheim, Germany), and the labeled probes were hybridized to metaphase cells from the proband as previously described (4).
The proband and three other family members (I-1, II-1, and II-3) were genotyped with polymorphic markers to exclude the possibility of maternal isodisomy of chromosome 7. Using previously described techniques, 14 short tandem repeat markers, including five markers from chromosome 7q34 -36 where HERG is encoded, were used to genotype participants (5) .
Biophysical characterization of HERG mutant. Chinese hamster ovary (CHO) cells were transiently transfected with wild-type HERG or HERG mutant (R752Q) cDNA. Cells were cultured in DMEM medium supplemented with 10% horse serum at 37°C, and transfected with lipofectamine according to the manufacturer's instructions (Invitrogen, Carlsbad, CA, U.S.A.). A plasmid encoding Green Fluorescent Protein (GFP) was cotransfected to assess transfection efficiency and to identify transfected cells for voltage-clamp analysis. The transfection mixture included 2 g of HERG isoforms (in pSI), 1 g of GFP/pRC CMV , and 12 L of lipofectamine reagent in 0.5 mL serum free DMEM for 6 -8 h, after which the standard medium was restored for 48 h.
Cells were briefly trypsinized before electrophysiologic study at room temperature (22-23°C). To obtain currentvoltage relations for HERG current, cells were held at Ϫ80 mV, activating currents were elicited with depolarizing pulses from Ϫ70 to ϩ60 mV in 10-mV steps, and deactivating tail currents were recorded upon repolarization to Ϫ40 mV. Pulses were delivered every 15 s. The voltage at which half the channels are activated (V 1/2 ) was obtained by fitting tail current amplitudes as a function of voltage to the Boltzmann equation:
Cell surface was obtained by integrating capacitative current recorded with brief steps to Ϫ90 mV, and tail current magnitudes were normalized to cell surface as pA/pF. Values were expressed as mean Ϯ SEM.
Solutions. The intracellular pipette filling solution contained 110 mM KCl, 5 mM K 4 BAPTA, 5 mM K 2 ATP, 1 mM MgCl 2 , and 10 mM HEPES. The solution was adjusted to pH 7.2 with KOH, yielding a final intracellular K ϩ concentration of approximately 145 mM. The extracellular solution was Tyrode's containing 130 mM NaCl, 4 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, and 10 mM glucose, and was adjusted to pH 7.35 with NaOH (6).
RESULTS
Clinical course of proband. In response to torsade de pointes recurrence, second-degree heart block occurrence, and ventricular function deterioration, a variety of interventions were performed. On a regimen of temporary, transvenous right ventricular pacing, magnesium, lidocaine, and propranolol, ventricular systolic function improved. A dual-chamber permanent pulse generator (Medtronic Thera DR #7968, Medtronic, Inc., Minneapolis, MN, U.S.A.) and epicardial pacing electrodes were implanted on d 5 of life. Left stellate ganglionectomy and potassium supplementation were added to the regimen after torsade de pointes recurrence. No subsequent ventricular tachycardia or bradycardia has been documented during 24 mo of follow-up. Except for a Horner syndrome related to stellate gan- glionectomy, there were no neurologic abnormalities in the proband and neurodevelopment has been normal.
Molecular genetic results.
A systematic survey of all coding regions of HERG, KVLQT1, KCNE1, and KCNE2 was performed using bidirectional sequencing. A G to A transition (G2255A) that changed the coding sense from arginine to glutamine (R752Q) was identified in HERG. Three asymptomatic family members (I-1, II-1, and II-4) were heterozygous for R752Q and the proband (III-1) was homozygous (Fig. 2) . Allele-specific oligonucleotide hybridization (ASO) was used to confirm R752Q and exclude its presence in 100 normal unrelated chromosomes (7). A previously identified KVLQT1 polymorphism (G643S) was identified in four family members (Fig. 2) (8) . Paternal DNA was unavailable for testing, and other family members have declined evaluation.
Fluorescence in-situ hybridization (FISH) revealed signals on both chromosome 7 homologs with no evidence of HERG deletion in the proband (not shown). Maternal isodisomy was excluded because the inheritance pattern at 11 chromosome 7 short tandem repeat polymorphic markers was consistent with biparental inheritance. These findings, taken together with homozygosity of three chromosome 7q35 markers, suggest recessive inheritance of the mutant HERG allele.
Biophysical characterization of HERG (R752Q).
Wild-type HERG generated robust I Kr , but no current was observed with the mutant HERG (R752Q; two independent clones) (Fig. 3) . (Fig. 1B) but normal in other family members (top right). Partial sequence of HERG and KVLQT1 (lower panel) illustrates the G2255A and G1927A transitions of HERG and KVLQT1, respectively. The HERG mutation changes the coding sense of codon 752 from arginine to glutamine; the proband is homozygous for glutamine at codon 752. The KVLQT1 sequence change is a previously reported polymorphism (8) .
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DISCUSSION
A HERG missense mutation, R752Q, results in absence of I Kr . In the homozygous state, the loss of functional I Kr creates the equivalent of a "HERG knockout" and leads to a severe phenotype initially manifest in utero. Intrauterine LQTS manifestations have been previously described (9 -11), but to our knowledge, the present report is the first example of intrauterine manifestations with subsequent genotype documentation. The heterozygous mutation is associated with a mild phenotype in this kindred, inasmuch as family members had neither symptoms nor electrocardiographic abnormalities. The reasons for the absent phenotype in this instance are currently unknown, but the association of LQTS gene mutations and reduced penetrance has been well described (12) .
Homozygous HERG mutations have been reported twice previously and in both cases were associated with severe LQTS in infants (13, 14) . L552S, also a HERG missense mutation, exhibited decreased channel activity at the end of the action potential; the severe phenotype of the homozygotes was thought to result from increased susceptibility to early after depolarizations (13) . Homozygosity for an insertion mutation predicted to result in premature truncation of the HERG protein would be expected to result in complete absence of I Kr , an effect similar to that observed in the proband we describe (14) .
Another HERG mutation in codon 752, R752W, has been reported to abrogate I Kr because the channels do not reach the cell surface (15) . R752Q may result in loss of HERG channel function because of a similar mechanism, or to abnormal gating. In either case, as shown in the present report, homozygosity of R752Q results in near-total loss of channel function, i.e. absence of I Kr .
The prevalence of ion channel sequence variants linked to arrhythmia risk in the general population may be relatively common (16) . By themselves, such variants may either confer no abnormal phenotype, or a mild phenotype in heterozygous individuals, but manifest with a severe phenotype in homozygotes or compound heterozygotes. Thus, careful family history and directed molecular genetic testing (although not yet clinically available) may become advisable when evaluating a newly diagnosed child with a severe arrhythmia phenotype. This may have implications for family members with a mild phenotype as their risk during treatment with certain drugs may be increased (17) , and their identification may allow avoidance of potentially adverse medication outcomes. 
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